Key Insights

Highlights

Success Rate

97% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

1.2%

1 terminated out of 81 trials

Success Rate

96.9%

+10.4% vs benchmark

Late-Stage Pipeline

5%

4 trials in Phase 3/4

Results Transparency

10%

3 of 31 completed with results

Key Signals

3 with results97% success

Data Visualizations

Phase Distribution

58Total
Not Applicable (42)
P 1 (4)
P 2 (8)
P 3 (4)

Trial Status

Completed31
Recruiting19
Unknown13
Not Yet Recruiting6
Active Not Recruiting5
Enrolling By Invitation3

Trial Success Rate

96.9%

Benchmark: 86.5%

Based on 31 completed trials

Clinical Trials (81)

Showing 20 of 20 trials
NCT07388550Phase 1Not Yet RecruitingPrimary

Phase I Open-Label Safety Trial of Pembrolizumab for Neurological Post- Acute Sequelae of SARS-CoV-2 (PD1-PASC I)

NCT07560059Completed

Acute Metabolic Outcomes in Diabetic Patients Hospitalized for COVID-19 (DMD-COV)

NCT07216040Not ApplicableNot Yet RecruitingPrimary

Harnessing Optimism and Perseverance in the Face of Long COVID-Español

NCT06095297Not ApplicableRecruiting

Long COVID Brain Fog: Cognitive Rehabilitation Trial

NCT05876377Active Not Recruiting

Use and Effectiveness of COVID-19 Vaccines Using State Vaccine Registries and Insurance Claims Data

NCT06168006Not ApplicableRecruitingPrimary

Exercise Training Using an App on Physical Cardiovascular Function Individuals With Post-covid-19 Syndrome

NCT05758558CompletedPrimary

Cognitive, Psychological, and Physical Functioning in Long-COVID Patients With Different Levels of Fatigue.

NCT06739668Not ApplicableCompletedPrimary

Humanity Neurotech Device Clinical Trial in Adults With Long COVID Cognitive Dysfunction

NCT06055244Phase 2Completed

Amantadine Therapy for Cognitive Impairment in Long COVID

NCT07189936Phase 2RecruitingPrimary

Effect of 2-HOBA in Persistent Immune Activation in Long COVID POTS

NCT04806620RecruitingPrimary

Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research

NCT07356570RecruitingPrimary

Second Prospective Cohort of Patients Entering the Multidisciplinary Care Pathway for Post-Covid Syndromes - SyPoCo2 Cohort

NCT06156202Not ApplicableCompleted

Evaluating a Comprehensive Multimodal Outpatient Rehabilitation Program for PASC Program to Improve Functioning of Persons Suffering From Post-COVID-19 Syndrome: A Randomized Controlled Trial

NCT05421208Not ApplicableRecruitingPrimary

Cardiovascular Autonomic and Immune Mechanism of Post COVID-19 Tachycardia Syndrome

NCT05926505Phase 2RecruitingPrimary

Safety and Efficacy of Anakinra Treatment for Patients With Post Acute Covid Syndrome

NCT05705193Not ApplicableRecruitingPrimary

Brain-Training Treatment for Long COVID in Older Adults

NCT05787379Not ApplicableRecruitingPrimary

Care for Veterans Post-COVID-19

NCT05676008Not ApplicableActive Not RecruitingPrimary

A Study of Positive Emotions With Long COVID-19

NCT07197138Not ApplicableRecruiting

IMPACT-D+: Immune-Modulating and Psychometric Effects of Accelerated TMS in Depression Plus Comorbid Post-COVID-19 Condition

NCT05441657Completed

Visualizing Regional Lung Ventilation in Patients With Postacute-COVID-19

Scroll to load more

Research Network

Activity Timeline